arginyl-threonyl-prolyl-prolyl-prolyl-seryl-glycine has been researched along with Breast Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cserni, G; Csörgő, E; Kelemen, G; Kővári, B; Lázár, P; Vörös, A | 1 |
1 other study(ies) available for arginyl-threonyl-prolyl-prolyl-prolyl-seryl-glycine and Breast Cancer
Article | Year |
---|---|
The use of digital images improves reproducibility of the ki-67 labeling index as a proliferation marker in breast cancer.
Topics: Adult; Aged; Antibodies, Antinuclear; Antibodies, Monoclonal; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Middle Aged; Oligopeptides; Reproducibility of Results | 2014 |